Zeli Yin

496 total citations
11 papers, 371 citations indexed

About

Zeli Yin is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Zeli Yin has authored 11 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Zeli Yin's work include Extracellular vesicles in disease (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and MicroRNA in disease regulation (3 papers). Zeli Yin is often cited by papers focused on Extracellular vesicles in disease (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and MicroRNA in disease regulation (3 papers). Zeli Yin collaborates with scholars based in China and United States. Zeli Yin's co-authors include Liming Wang, Chengyong Dong, Keqiu Jiang, Rui Li, Kun Guo, Shujuan Shao, Qi Wang, Junlin Zhang, Zhenming Gao and Rui Li and has published in prestigious journals such as Molecular Cancer, Carcinogenesis and Journal of Cellular Biochemistry.

In The Last Decade

Zeli Yin

10 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zeli Yin China	8	217	199	100	84	62	11	371
Man Xia China	12	253 1.2×	170 0.9×	73 0.7×	86 1.0×	29 0.5×	22	399
Anja von Au Germany	7	188 0.9×	91 0.5×	72 0.7×	61 0.7×	26 0.4×	9	326
Nadia Tosti Switzerland	10	162 0.7×	166 0.8×	135 1.4×	46 0.5×	66 1.1×	16	328
Shenglan Huang China	11	150 0.7×	95 0.5×	69 0.7×	48 0.6×	66 1.1×	23	295
Elena Menietti Switzerland	5	174 0.8×	81 0.4×	219 2.2×	69 0.8×	38 0.6×	7	357
Kazuma Ohtaka Japan	7	201 0.9×	174 0.9×	147 1.5×	36 0.4×	48 0.8×	8	381
Xinhui Liu China	13	425 2.0×	319 1.6×	99 1.0×	41 0.5×	76 1.2×	27	579
Anke Van den broeck Belgium	6	233 1.1×	128 0.6×	285 2.9×	53 0.6×	46 0.7×	9	433
Lanshan Huang China	12	198 0.9×	148 0.7×	81 0.8×	41 0.5×	53 0.9×	24	352
Tiening Zhang China	6	168 0.8×	126 0.6×	98 1.0×	92 1.1×	70 1.1×	10	335

Countries citing papers authored by Zeli Yin

Since Specialization

Citations

This map shows the geographic impact of Zeli Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeli Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeli Yin more than expected).

Fields of papers citing papers by Zeli Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeli Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeli Yin. The network helps show where Zeli Yin may publish in the future.

Co-authorship network of co-authors of Zeli Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Zeli Yin. A scholar is included among the top collaborators of Zeli Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeli Yin. Zeli Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Liu, Jason, et al.. (2025). Multi-omics analysis reveals the prognostic value and immunomodulatory role of CTSW in breast cancer. Discover Oncology. 16(1). 1739–1739.

Song, Yilin, et al.. (2024). The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy. Frontiers in Oncology. 13. 1299384–1299384. 9 indexed citations

Yin, Zeli, et al.. (2024). Single-cell RNA sequencing reveals the landscape of the cellular ecosystem of primary hepatocellular carcinoma. Cancer Cell International. 24(1). 379–379. 2 indexed citations

Yin, Zeli & Liming Wang. (2023). Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy. Annals of Medicine. 55(1). 1058–1069. 14 indexed citations

Guo, Kun, Yang Zhou, Yidan Zhao, et al.. (2022). Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma. Cancer Gene Therapy. 29(12). 1951–1960. 37 indexed citations

Jiang, Keqiu, Chengyong Dong, Zeli Yin, et al.. (2020). Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis. Cell Death and Disease. 11(11). 972–972. 77 indexed citations

Li, Rui, Chengyong Dong, Keqiu Jiang, et al.. (2020). Rab27B enhances drug resistance in hepatocellular carcinoma by promoting exosome-mediated drug efflux. Carcinogenesis. 41(11). 1583–1591. 25 indexed citations

Wang, Xiaobin, Zeli Yin, Yanyun Zhao, et al.. (2020). Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database. Molecular Medicine Reports. 21(3). 1647–1657. 6 indexed citations

Yin, Zeli, Chengyong Dong, Keqiu Jiang, et al.. (2019). Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. Journal of Hematology & Oncology. 12(1). 101–101. 132 indexed citations

10.

Yin, Zeli, Keqiu Jiang, Rui Li, Chengyong Dong, & Liming Wang. (2018). Multipotent mesenchymal stromal cells play critical roles in hepatocellular carcinoma initiation, progression and therapy. Molecular Cancer. 17(1). 178–178. 59 indexed citations

11.

Jiang, Keqiu, Chengyong Dong, Zeli Yin, et al.. (2018). The critical role of exosomes in tumor biology. Journal of Cellular Biochemistry. 120(5). 6820–6832. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact